2021 IPO

Rani Therapeutics Stock

Rani Therapeutics develops bio-therapeutics technology for the oral delivery of large drug molecules.

Sign up today and learn more about Rani Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Rani Therapeutics Stock

Rani Therapeutics, LLC develops a oral biotherapeutics technology for the oral delivery of large drug molecules, including peptides, proteins, and antibodies. The company is based in San Jose, California.

Funding History

June 2012$4.0M
July 2013$9.4M
May 2015$37.1M
September 2017$39.0M
February 2018$53.0M


Vice President, Finance & Operations

Syed Zaidi

Vice President, Research & Development

Mir Hashim

Founder, Chairman & CEO

Mir Imran

Vice President, Operations

Bob Gaffney

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: